Transformation and additional malignancies are leading risk factors for an adverse course of disease in marginal zone lymphoma
Meyer, A.H., Stroux, A., Lerch, K., Eucker, J., Eitle, J., Hohloch, K., Andrzejak, M., Possinger, K., Dörken, B., Pezzutto, A., Scholz, C.W.
Published in Annals of oncology (01.01.2014)
Published in Annals of oncology (01.01.2014)
Get full text
Journal Article
Safety and efficacy of Temsirolimus in combination with Bendamustine and Rituximab in relapsed mantle cell and follicular lymphoma
Hess, G, Keller, U, Scholz, C W, Witzens-Harig, M, Atta, J, Buske, C, Kirschey, S, Ruckes, C, Medler, C, van Oordt, C, Klapper, W, Theobald, M, Dreyling, M
Published in Leukemia (01.08.2015)
Published in Leukemia (01.08.2015)
Get full text
Journal Article
HIGH RATE OF METABOLIC COMPLETE RESPONSE AFTER LOW DOSE RADIOTHERAPY AND OBINUTUZUMAB IN EARLY STAGE FOLLICULAR LYMPHOMA: INITIAL RESULTS OF THE GAZAI STUDY (GLA 2018‐3)
Herfarth, K., Scholz, C. W., Hübel, K., Wirths, S., Buske, C., Dürig, J., Forstpointner, R., Heidegger, S., Lenz, G., König, L., Meißner, J., Höller, U., Baues, C., De‐Colle, C., Wiegel, T., Gauler, T., Li, M., Combs, S. E., Eich, H., Sander, A., Mavriopuoluo, E., Kieser, M., Pott, C., Dreyling, M.
Published in Hematological oncology (01.06.2023)
Published in Hematological oncology (01.06.2023)
Get full text
Journal Article
INMIND: A PHASE 3 STUDY OF TAFASITAMAB + LENALIDOMIDE AND RITUXIMAB VS PLACEBO + LENALIDOMIDE AND RITUXIMAB FOR RELAPSED/REFRACTORY FOLLICULAR OR MARGINAL ZONE LYMPHOMA
Hübel, K., Scholz, C. W., Luminari, S., Salar, A., Wahlin, B. E., Gopal, A. K., Bonnet, C., Trneny, M., Paneesha, S., Manzke, O., Seguy, F., Li, D., Sehn, L. H.
Published in Hematological oncology (01.06.2021)
Published in Hematological oncology (01.06.2021)
Get full text
Journal Article
Radioimmunotherapy for first-line and relapse treatment of aggressive B-cell non-Hodgkin lymphoma: an analysis of 215 patients registered in the international RIT-Network
Hohloch, Karin, Lankeit, H. K., Zinzani, P. L., Scholz, C. W., Lorsbach, M., Windemuth-Kieselbach, C., Trümper, L.
Published in European journal of nuclear medicine and molecular imaging (01.08.2014)
Published in European journal of nuclear medicine and molecular imaging (01.08.2014)
Get full text
Journal Article
Radioimmunotherapy in relapsed/refractory mantle cell lymphoma patients: final results of a European MCL Network Phase II Trial
Ferrero, S, Pastore, A, Scholz, C W, Forstpointner, R, Pezzutto, A, Bergmann, L, Trümper, L, Finke, J, Keller, U, Ghione, P, Passera, R, Hiddemann, W, Weigert, O, Unterhalt, M, Dreyling, M
Published in Leukemia (01.04.2016)
Published in Leukemia (01.04.2016)
Get full text
Journal Article
Impact of prior treatment on outcome of transformed follicular lymphoma and relapsed de novo diffuse large B cell lymphoma: a retrospective multicentre analysis
Lerch, K., Meyer, A. H., Stroux, A., Hirt, C., Keller, U., Viardot, A., Marks, R., Schreiber, S., Pezzutto, A., Scholz, C. W.
Published in Annals of hematology (01.06.2015)
Published in Annals of hematology (01.06.2015)
Get full text
Journal Article
P1103: INMIND: A PHASE 3 STUDY OF TAFASITAMAB PLUS LENALIDOMIDE AND RITUXIMAB VERSUS PLACEBO PLUS LENALIDOMIDE AND RITUXIMAB FOR RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA (FL) OR MARGINAL ZONE LYMPHOMA (MZL)
Sehn, L. H., Hübel, K., Luminari, S., Salar, A., Wahlin, B. E., Gopal, A. K., Bonnet, C., Paneesha, S., Trneny, M., Mashegu, H., Lihou, C., Li, D., Scholz, C. W.
Published in HemaSphere (23.06.2022)
Published in HemaSphere (23.06.2022)
Get full text
Journal Article
P1125: CELESTIMO: A PHASE III TRIAL EVALUATING THE EFFICACY AND SAFETY OF MOSUNETUZUMAB PLUS LENALIDOMIDE VERSUS RITUXIMAB PLUS LENALIDOMIDE IN PATIENTS WITH RELAPSED OR REFRACTORY FOLLICULAR LYMPHOMA
Nastoupil, L., Morschhauser, F., Scholz, C. W., Bishton, M., Yoon, S.‐S., Giri, P., Wei, M. C., Knapp, A., Li, C.‐C., Bottos, A., Li, H., Purev, E., Bartlett, N. L.
Published in HemaSphere (23.06.2022)
Published in HemaSphere (23.06.2022)
Get full text
Journal Article
Phase I trial with carboplatin and RAD001 in metastatic breast cancer
Eucker, J., Schwarzlose-Schwarck, S., Martus, P., Regierer, A. C., Schulz, C. O., Liu, H., Scholz, C. W., Schefe, J. H., Possinger, K.
Published in Journal of clinical oncology (20.05.2011)
Published in Journal of clinical oncology (20.05.2011)
Get full text
Journal Article
inMIND: A phase 3 study of tafasitamab plus lenalidomide and rituximab versus placebo plus lenalidomide and rituximab for relapsed/refractory follicular or marginal zone lymphoma
Sehn, Laurie Helen, Hübel, Kai, Luminari, Stefano, Salar, Antonio, Wahlin, Bjorn E., Gopal, Ajay K., Bonnet, Christophe Marc, Paneesha, Shankara, Trneny, Marek, Mashegu, Hafsat Umar, Lihou, Christine Francis, Li, Di, Scholz, Christian W.
Published in JOURNAL OF CLINICAL ONCOLOGY (01.06.2022)
Published in JOURNAL OF CLINICAL ONCOLOGY (01.06.2022)
Get full text
Journal Article
Conference Proceeding
A phase 3 study to evaluate the efficacy and safety of tafasitamab plus lenalidomide and rituximab versus placebo plus lenalidomide and rituximab in patients with relapsed/refractory (R/R) follicular lymphoma (FL) or marginal zone lymphoma (MZL)
Sehn, Laurie Helen, Scholz, Christian W, Luminari, Stefano, Salar, Antonio, Wahlin, Bjorn E., Gopal, Ajay K., Bonnet, Christophe Marc, Paneesha, Shankara, Manzke, Oliver, Seguy, Francis, Li, Di, Hübel, Kai
Published in JOURNAL OF CLINICAL ONCOLOGY (20.05.2021)
Published in JOURNAL OF CLINICAL ONCOLOGY (20.05.2021)
Get full text
Journal Article
Conference Proceeding
Systemic and intrathecal chemotherapy followed by high-dose chemotherapy with autologous stem cell transplantation (HD-ASCT) for CNS relapse of aggressive lymphomas: A potentially curative approach?
Fischer, L., Haenel, M., Moehle, R., Schroers, R., Elter, T., Reiser, M., Dreyling, M. H., Illerhaus, G., Eucker, J., Scholz, C. W., Metzner, B., Roeth, A., Birkmann, J., Schlegel, U., Martus, P., Thiel, E., Korfel, A.
Published in Journal of clinical oncology (20.05.2011)
Published in Journal of clinical oncology (20.05.2011)
Get full text
Journal Article
International validation of the EORTC QLQ‐CLL17 questionnaire for assessment of health‐related quality of life for patients with chronic lymphocytic leukaemia
Oerlemans, Simone, Efficace, Fabio, Kieffer, Jacobien M., Kyriakou, Charalampia, Xochelli, Aliki, Levedahl, Kerstin, Petranovic, Duska, Borges, Fabio Cardoso, Bredart, Anne, Shamieh, Omar, Gziskevicius, Laimonas, Lehmann, Jens, Scholz, Christian W., Caocci, Giovanni, Molica, Stefano, Stamatopoulos, Kostas, Panteliadou, Alkistis‐Kyra, Papaioannou, Maria, Alrjoob, Waleed, Baliakas, Panagiotis, Rosenquist, Richard, Malak, Sandra, Miranda, Ana, Cocks, Kim, Poll‐Franse, Lonneke
Published in British journal of haematology (01.05.2022)
Published in British journal of haematology (01.05.2022)
Get full text
Journal Article
P1103: INMIND: A PHASE 3 STUDY OF TAFASITAMAB PLUS LENALIDOMIDE AND RITUXIMAB VERSUS PLACEBO PLUS LENALIDOMIDE AND RITUXIMAB FOR RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA (FL) OR MARGINAL ZONE LYMPHOMA (MZL)
Sehn, L. H., Hübel, K., Luminari, S., Salar, A., Wahlin, B. E., Gopal, A. K., Bonnet, C., Paneesha, S., Trneny, M., Mashegu, H., Lihou, C., Li, D., Scholz, C. W.
Published in HemaSphere (01.06.2022)
Published in HemaSphere (01.06.2022)
Get full text
Journal Article
inMIND: A Phase 3 Study of Tafasitamab Plus Lenalidomide and Rituximab Versus Placebo Plus Lenalidomide and Rituximab for Relapsed/Refractory (R/R) Follicular Lymphoma (FL) or Marginal Zone Lymphoma (MZL)
Sehn, LH, Hubel, K, Luminari, S, Salar, A, Wahlin, BE, Gopal, AK, Bonnet, C, Paneesha, S, Trneny, M, Mashegu, H, Lihou, CF, Cheng, L, Scholz, CW
Published in CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2022)
Get full text
Published in CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2022)
Conference Proceeding
inMIND: A Phase 3 Study of Tafasitamab plus Lenalidomide Add-On to Rituximab vs Placebo plus Lenalidomide Add-On to Rituximab for Relapsed/Refractory (R/R) Follicular Lymphoma (FL) or Marginal Zone Lymphoma (MZL)
Sehn, LH, Scholz, CW, Luminari, S, Salar, A, Wahlin, BE, Gopal, AK, Bonnet, C, Trneny, M, Paneesha, S, Manzke, O, Seguy, F, Li, D, Hubel, K
Published in CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2021)
Get full text
Published in CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2021)
Conference Proceeding
Predicting Highway Accident Severity in Brazil: Environmental Factors and Vehicle Features
Scholz, Julio C. W., Pinheiro, Yan P., Silva, Thiago H.
Published in 2024 20th International Conference on Distributed Computing in Smart Systems and the Internet of Things (DCOSS-IoT) (29.04.2024)
Published in 2024 20th International Conference on Distributed Computing in Smart Systems and the Internet of Things (DCOSS-IoT) (29.04.2024)
Get full text
Conference Proceeding